Ask HopeStage to review this study with me
Study ID: NCT06973551. We help you review the study, but cannot decide medical eligibility.
CompletedNCT06973551
Culturally Familiar Nostalgic VR Cognitive Training for Older Adults
This study is completed. It focuses on depression and currently lists study information in Taiwan.
Depression, Mild Cognitive Impairment (MCI), ...BehavioralOver 65 Years
Key information made simple
This observational study is following people with Mild Cognitive Impairment, Dementia, Cognitive Decline, or Psychological Well-being to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.
Your next step
The official record suggests a mix of remote and in-person participation through a university, with sites including National Taiwan Normal University in Taipei. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually being able to understand the study and consent, while common reasons not to take part include major medical issues that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: April 29, 2025
- Recruitment status
- Completed
- Estimated enrollment
- Not clearly listed
- Sponsor
- National Taiwan Normal University
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioral / psychological / psychosocial
- Study phase
- Not clearly listed
- Locations
- Taiwan
- Age range
- Over 65 Years
- Official registry ID
- NCT06973551
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT06973551. We help you review the study, but cannot decide medical eligibility.
Key study information
- Condition
- Depression, Mild Cognitive Impairment (MCI), ...
- Study status
- Completed
- Sponsor / lead affiliation
- National Taiwan Normal University
- Location / country
- Taiwan
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT06973551
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help test a support approach in real life.
It requires regular visits and structured follow-up.
Mixes in-person and remote participation.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring behavioral or lifestyle intervention for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study. Phase is mainly useful to check for medication studies and some device studies.
Who might this study be for?
This study may concern people with depression; age range: Over 65 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Could this study affect my mood, habits, motivation, or stress?
Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by National Taiwan Normal University, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that this study is completed. It may still be useful for understanding the research, but you are unlikely to be able to join.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meOther studies you may want to explore next
TerminatedNCT05518149
Aticaprant in Adult and Elderly people with Major Depressive Disorder (MDD)
This study has public registry information in the United States, in Australia, in France, .... It is testing aticaprant for depression.
RecruitingNCT07412756
Brenipatide in adults with Major Depressive Disorder
This study is recruiting in the United States, in Australia, in Canada, .... It is testing brenipatide for depression.
RecruitingNCT07227454
Esketamine for depression
This study is recruiting in the United States, in Brazil, and in Taiwan. It is testing esketamine for depression.